Influencing policy

Science policy affects a broad range of issues, ranging from data sharing and gene editing, to intellectual property and regulation.

Our work

Good clinical practice guidelines

New clinical practice guidelines are urgently needed for trials where the current guidelines are not fit for purpose.

Access to healthcare interventions

Everyone should have access to the life-changing benefits of medicines and other healthcare interventions, like vaccines, diagnostics and therapies.

Open research

We want the research we fund – like publications, data, software and materials – to be open and accessible, so it can have the greatest possible impact.

Brexit and the EU

We're working with the UK government and others to achieve a Brexit settlement that allows research to thrive in the UK and Europe.

Emerging science and technologies

Emerging science and technologies, such as human genome editing and gene drive, could provide new solutions to health problems.

Patient data in research

Patient data is hugely valuable for research. But the value of that data can only be unlocked if concerns about patient privacy are taken seriously.

Government investment in research

Government investment plays an important part in supporting scientific excellence in the UK.

Data sharing in public health emergencies

Research is an essential part of being ready for and responding to public health emergencies.

Data Protection Regulation

The European General Data Protection Regulation was agreed in April 2016 and took effect from 25 May 2018.

EU copyright law reform

The European Commission has published a proposal to update EU copyright law so that it applies equally across Europe and is fit for purpose in the 21st century.

Research involving animals

Almost every major breakthrough in human and veterinary medicine has depended on the use of animals to research, develop or test new therapies.

Mitochondrial donation

Mitochondrial donation is an IVF technique that gives families affected by mitochondrial disease the chance of having healthy children.

EU medical devices regulations

The European Union is revising regulations governing the manufacture and sale of medical devices.

Expert Advisory Group on Data Access

The Expert Advisory Group on Data Access promoted good working practices, consistent governance and transparent decision making for managing and using data from cohort studies.

Research practice

Good research practice is one of the foundations of high-quality research.

Accelerated Access Review

The recommendations set out in the review mark one of the first steps towards making sure that promising drugs, devices, diagnostics and digital products are adopted quickly across the NHS.

Reports

Exploring good clinical practice in clinical trials [PDF 124KB]

  • February 2019

Our workshop with the Gates Foundation and the Academy of Medical Sciences looked at how the current guidelines for clinical trials could be improved, and possible alternative approaches.

Brexit and Beyond: clinical trials [PDF 969KB]

  • February 2019

We explore options for the regulation of clinical trials in the UK after Brexit.

Data policy models for funding bodies [PDF 858KB]

  • December 2018

How funders can work with the research community to improve data access, governance and management.

More reports

Briefings and responses